InvestorsHub Logo
Followers 22
Posts 2481
Boards Moderated 2
Alias Born 09/15/2011

Re: None

Friday, 03/08/2019 9:08:34 AM

Friday, March 08, 2019 9:08:34 AM

Post# of 14689
Generex Biotechnology Subsidiary Olaregen Therapeutix Announces the Appointment of Vice President of Business Strategy
9:00 AM ET, 03/08/2019 - GlobeNewswire
Industry Veteran John P. Sentman to Lead Strategic Sales and Partnering

MIRAMAR, FL, March 08, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Olaregen Therapeutix, a subsidiary of Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) (http://www.otcmarkets.com/stock/GNBT/quote) is proud to announce the appointment of John P. Sentman as Vice President of Business Strategy. In his position, Mr. Sentman will lead and coordinate the activities and operations of the business strategy department responsible for executing all aspects of the organization’s overall business strategy, sales and market planning, and financial forecasts.

Mr. Sentman has over 30 years of experience in commercial, marketing, and strategic planning roles within the medical device industry, primarily in the wound care field. He joins Olaregen from Integra Life Sciences where he was Senior Director of Global Marketing for Regenerative Technologies, overseeing brand marketing of the company’s soft tissue repair portfolio. Prior to Integra, Mr. Sentman held various sales, management, and marketing roles, both domestically and internationally over a 20-year career with ConvaTec, a leading manufacturer of wound care products. Mr. Sentman received his bachelor’s degree in finance from American University’s School of Business.

“We are extremely pleased to have John leading business strategy, market development and the commercial launch of Excellagen,” said Anthony Dolisi, CEO of Olaregen and Chief Commercial Officer of Generex. “His extensive wound care experience and market knowledge will be instrumental to the company’s commercial success.”

Mr. Sentman commented on his new position, “I welcome the opportunity to launch and build the Excellagen brand as the leading Cellular Tissue Product in treating hard-to-heal wounds, and I look forward to working closely with the Olaregen team.
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.